USPTO serial 79312452
CYTED
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 4, 2023
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CYTED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MICHAEL R. FRISCIA
Michael R. Friscia McCarter & English, LLP100 Mulberry StreetFour Gateway CenterNewark, NJ 07102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for cancer and gastrointestinal disease screening and diagnostic purposes for use in medical decision support systems | ACTIVE | — |
| 010 | Diagnostic imaging apparatus for medical use; diagnostic testing apparatus for use in medical immunoassay procedures; diagnostic testing apparatus for use in medical molecular analyses; diagnostic, examination, and monitoring equipment for medical use and pathology, namely, for cancer and gastrointestinal disease; diagnostic instruments for medical use for pathology for detecting cancer and gastrointestinal disease; diagnostic measuring apparatus for medical use and pathology, namely, for cancer and gastrointestinal disease; medical diagnostic apparatus for medical purposes and pathology, namely, for cancer and gastrointestinal disease; medical diagnostic instruments for medical use for pathology, namely, for cancer and gastrointestinal disease | ACTIVE | — |
| 042 | Medical laboratories; medical and pharmacological research services; medical laboratory services; medical research; medical research laboratory services; medical research services; software as a service (SaaS) services featuring software for identifying markers for screening and diagnostic purposes for cancer and gastrointestinal disease; software creation; software customisation services; software design; software design and development; biomedical research services; design and development of medical technology; design and development of computer software for use with medical technology; platforms for artificial intelligence as software as a service (SaaS), namely, software as a service (SaaS) services featuring software for identifying markers for screening and diagnostic purposes for cancer and gastrointestinal disease; database design and development; design and development of computer database programs and software; design and development of computer software for use with medical technology, logistics, reading data, supply chain management; design and development of computer software architecture; design and development of data display entry and output systems, data processing apparatus, programmes, software and systems; design and development of diagnostic apparatus | ACTIVE | — |
| 044 | Medical services; medical testing, screening and diagnostic services for cancer and gastrointestinal disease; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; medical advisory services; medical treatment services, for pathology; arranging of medical treatment, namely, providing medical diagnostic testing, monitoring and reporting services for pathology in the field of cancer and gastrointestinal disease; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; medical analysis services for cancer and gastrointestinal disease, namely, screening and diagnostics; medical examination of individuals; medical and healthcare clinics being facilities with access for patients; providing medical information regarding testing and diagnosis of diseases and infections; providing medical information regarding diagnosis and treatment of diseases and infections; medical analysis services for cancer diagnosis and prognosis; medical analysis services relating to the treatment of patients and persons; medical analysis services, for screening and diagnostic purposes provided by medical laboratories; medical laboratory services for the analysis of samples taken from patients; medical services relating to the removal, treatment and processing of human cells; computer aided medical diagnostic testing services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cyted Ltd
- Other trademarks owned by Cyted Ltd
- Other trademarks owned by Cyted Ltd
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CYTED
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 14, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 23, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 20, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 20, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 4, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 21, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 4, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 4, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 4, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 28, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 12, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 12, 2022 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Nov 27, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 23, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 23, 2022 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Nov 23, 2022 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 23, 2022 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Nov 9, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 9, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 6, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 6, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 6, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 31, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 31, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 31, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 29, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 29, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 28, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 27, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 7, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |